(Bloomberg) -- For years, Barclays Plc struggled with what to do about its US credit-card business. It was a cash generator, cranking out a steady stream of revenue, and yet it was costly to run because of the way regulators force banks to set …
Achieves first quarter revenue growth of 7% as reported and organic, supported by CAG Diagnostics recurring revenue growth of 7% as reported and organic Solid growth supported by continued benefits from IDEXX execution drivers including double-digit year-over-year installed base growth across global premium instrument …
Record first quarter Housing and Infrastructure Products (HIP) income from operations of $210 million with a 20% operating income margin HIP EBITDA of $264 million rose 29% year-over-year with a record first quarter EBITDA margin of 25% PEM sales volume grew 3% sequentially from …
The FlexShares International Quality Dividend ETF (IQDF) made its debut on 04/12/2013, and is a smart beta exchange traded fund that provides broad exposure to the World ETFs category of the market. What Are Smart Beta ETFs? The ETF industry has long been dominated …
Key Insights Expeditors International of Washington to hold its Annual General Meeting on 7th of May CEO Jeff Musser's total compensation includes salary of US$100.0k The overall pay is comparable to the industry average Expeditors International of Washington's total shareholder return over the past …
Key Insights Danaher to hold its Annual General Meeting on 7th of May CEO Rainer Blair's total compensation includes salary of US$1.30m The total compensation is 126% higher than the average for the industry Over the past three years, Danaher's EPS fell by 5.3% …
Many car shoppers simply want a vehicle that’s practical, easy to drive and relatively inexpensive. High fuel economy is increasingly a popular desire as well. If this sounds like what you’re looking for in your next vehicle, consider the 2024 Kia Niro or the …
It's been a mediocre week for Transocean Ltd. (NYSE:RIG) shareholders, with the stock dropping 12% to US$5.22 in the week since its latest first-quarter results. Revenues of US$763m reported a marginal miss, falling short of forecasts by 2.2%, but earnings were better than expected …
Iovance Biotherapeutics, Inc. SAN CARLOS, Calif., May 01, 2024 (GLOBE NEWSWIRE) -- Iovance Biotherapeutics, Inc. (NASDAQ: IOVA), a biotechnology company focused on innovating, developing, and delivering novel polyclonal tumor infiltrating lymphocyte (TIL) therapies for patients with cancer, will report its first quarter 2024 financial …
This is The Takeaway from today's Morning Brief, which you can sign up to receive in your inbox every morning along with: The chart of the day What we're watching What we're reading Economic data releases and earnings Stocks tumbled into the close on …